Investigational Site Number :8040001

Kryvyi Rih 50048

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Cancer Metastatic

Studies at this site

• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early